Peyton Fleagle was just a toddler when his parents first noticed itchy scales appear on his skin. Eventually, the scales covered 95% of Peyton’s body.
Fleagle, who is now 12, has a condition called X-linked ichthyosis, one of an often-disfiguring group of...
A medication that has been found to effectively treat the skin disease alopecia areata in adults is also successful in treating adolescent patients, according to a Yale-led clinical trial.
Alopecia areata is an autoimmune disease characterized by sudden,...
Just a year after the U.S. Food and Drug Administration (FDA) approved the first treatment for severe alopecia areata, the federal agency has approved a second treatment for the disfiguring skin disease — both the result of pioneering research by the same...
To Jodi Sherman’s way of thinking, the Hippocratic Oath’s vow of doing no harm includes doing no harm to the planet — particularly when it comes to the sea of single-use plastic flooding the health care industry.
Sherman, an associate professor of...
Nearly 30 years ago, scientists discovered a unique class of anticancer molecules in a family of bryozoans, a phylum of marine invertebrates found in tropical waters.
The chemical structures of these molecules, which consist of a dense, highly complex...
A new Yale study finds an increased risk of hospital readmission for older Americans within 180 days of undergoing major surgery — a risk that is particularly acute for individuals who are frail or have dementia.
The findings were published Feb. 28 in the...
Two Yale faculty members — a trailblazing astrophysicist and a leading immunologist — are part of Time Magazine’s 2024 list of the 100 most influential people in the world.
Priyamvada Natarajan, whose theories on the unseen forces underpinning the...
A new, Yale-led study suggests that a range of respiratory viral infections — including COVID-19 and influenza — may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
A team led by Yale’s Akiko Iwasaki and...